To evaluate the methodological quality of published clinical practice guidelines for benign prostatic hyperplasia.
PubMed, EMbase, CNKI, WanFang Data, VIP and CBM databases, website of Yimaitong, and international authoritative guide platforms were electronically searched to collect the relevant clinical practice guidelines or consensus for benign prostate hyperplasia. The retrieval covered the time up to December 13th, 2016. Literatures were independently screened by 2 reviewers. After data extraction, the methodological quality of included guidelines was evaluated by 4 reviewers using the AGREE Ⅱ. Each domain score was calculated and the intraclass correlation coefficient was used to evaluate the consistency among the reviewers.
A total of 15 clinical practice guidelines were included. The mean scores for the six domains in AGREE Ⅱ were: 72%, 38%, 30%, 58%, 16%, and 40%, respectively. The intraclass correlation coefficient was larger than 0.87, which indicated the total consistency was well.
The quality of clinical practice guidelines for benign prostatic hyperplasia is not satisfactory as expected. They are heterogeneous in quality and some requires improvement. Guidelines are required to be further developed in methodology in future, especially in three domains, including participants, preciseness and applicability of the design.
LI Sheng, ZENG Xiantao, LI Xiaodong, WU Kaijie, ZI Hao, HE Dalin, WANG Xinghuan. Quality assessment of clinical practice guidelines for benign prostatic hyperplasia. Chinese Journal of Evidence-Based Medicine, 2018, 18(1): 74-80. doi: 10.7507/1672-2531.201704003